ASCT: A Viable First-Line Treatment Option for Elderly Multiple Myeloma Patients Without Access to New Drugs

被引：0
|
作者：
Americo, Andre Dias [1 ]
Pittol, Isabella Silva Pimentel [1 ]
Pessoa, Juliana Matos [1 ]
Figueiroa, Hegta [1 ]
Ayoub, Fauze Lutfe [2 ]
de Medeiros Lima, Germano Glauber [2 ]
Zenero, Paula Lucafo [2 ]
Gusmao, Breno [1 ]
Kerbauy, Fabio [1 ]
Amigo Filho, Jose Ulysses [1 ]
Scheinberg, Phillip [1 ]
机构：
[1] Beneficencia Portuguesa Sao Paulo, Sao Paulo, Brazil
[2] Hosp Municipal Brigadeiro, Sao Paulo, Brazil
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-331
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [1] ASCT: A Viable First-Line Treatment Option for Elderly Multiple Myeloma Patients Without Access to New Drugs
    Pimentel Pittol, Isabella Silva
    Pessoa, Juliana Matos
    Americo, Andre Dias
    Rodrigues Figueroa, Hegta Taina
    Ayoub, Fauze Lufte
    de Medeiros Lima, Germano Glauber
    Zenero, Paula Lucafo
    Gusmao, Breno Moreno
    Kerbauy, Fabio Rodrigues
    Amigo Filho, Jose Ulysses
    Scheinberg, Phillip
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S558 - S558
  • [2] First-line treatment of multiple myeloma
    Breitkreutz, I
    Raab, M.
    Goldschmidt, H.
    INTERNIST, 2019, 60 (01): : 23 - 33
  • [3] Efficacy of Bortezomib as First-Line Treatment for Patients with Multiple Myeloma
    Painuly, Utkarsh
    Kumar, Shaji
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 53 - 73
  • [4] First-line treatment in elderly patients
    Montefusco, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S19 - S19
  • [5] First-line Autologous Stem Cell Transplantation (ASCT) in elderly Multiple Myeloma (MM) patients: impact of melphalan dosage and clinical variables on outcome
    Belotti, A.
    Morello, E.
    Crippa, C.
    Ribolla, R.
    Orlando, V.
    Rossi, G.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S304 - S304
  • [6] Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple Myeloma
    Klein, Eva-Maria
    Hujic, Sejla
    Miah, Kaya
    Benner, Axel
    Merz, Maximilian
    Bertsch, Uta
    Weinhold, Niels
    Goldschmidt, Hartmut
    Sauer, Sandra
    ONCOLOGY, 2024,
  • [7] First-line bortezomib benefits patients with multiple myeloma
    Meletios A. Dimopoulos
    Evangelos Terpos
    Nature Reviews Clinical Oncology, 2009, 6 : 683 - 685
  • [8] Intercalated chemotherapy and erlotinib: a viable first-line option for patients with advanced NSCLC?
    Zheng, Yulong
    Xu, Nong
    Zhou, Jianying
    LANCET ONCOLOGY, 2013, 14 (11): : E438 - E438
  • [9] First-Line Treatment of Multiple Myeloma in Elderly Patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Multiple Myeloma Working Party Perspective
    Musto, Pellegrino
    D'Auria, Fiorella
    Pietrantuono, Giuseppe
    Baldini, Luca
    Bringhen, Sara
    Caravita, Tommaso
    Di Raimondo, Francesco
    Morabito, Fortunato
    Offidani, Massimo
    Petrucci, Maria Teresa
    Tosi, Patrizia
    Gay, Francesca
    Cavo, Michele
    Boccadoro, Mario
    Palumbo, Antonio
    CURRENT DRUG TARGETS, 2009, 10 (10) : 906 - 922
  • [10] BORTEZOMIB IN THE FIRST-LINE TREATMENT OF MULTIPLE MYELOMA: THE EXPERIENCE OF A CENTER
    Mendes, M. J.
    Ferreira, G.
    Saturnino, H.
    Duarte, M.
    Almeida, J. C.
    Arajo, L. F.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2015, 100 : 735 - 735
12345